Top 50 Biotech Startup Investors in Spain (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Inveready
VC Fund
|
38 | Spain, United States, France | Seed, Venture - Series Unknown, Debt Financing | Software, Biotechnology, Health Care | $400k–$6.5M |
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
33 | Spain, United States, United Kingdom | Grant, Seed, Venture - Series Unknown | Biotechnology, Health Care, Software | $167k–$26M |
|
Invivo Capital Partners
VC Fund
|
22 | Spain, France, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
|
SODENA
VC Fund
|
20 | Spain, United Kingdom | Debt Financing, Seed, Venture - Series Unknown | Health Care, Biotechnology, Manufacturing | $37k–$3.5M |
|
Criteria Venture Tech
VC Fund
|
20 | Spain, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, E-Commerce | $303k–$21M |
|
Clave Capital
VC Fund
|
19 | Spain, Chile, Switzerland | Seed, Venture - Series Unknown, Series A | Biotechnology, Software, Health Care | $462k–$21M |
|
ENISA
VC Fund
|
16 | Spain, United States, France | Debt Financing, Seed, Pre-Seed | Software, Health Care, Artificial Intelligence | $73k–$1.6M |
|
BeAble Capital
VC Fund
|
15 | Spain, Italy | Pre-Seed, Seed, Venture - Series Unknown | Biotechnology, Manufacturing, Life Science | $132k–$16M |
|
Asabys Partners
VC Fund
|
14 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.3M–$135M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
14 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed, Grant | Biotechnology, Health Care, Medical | $260k–$16M |
|
ICF Capital
VC Fund
|
13 | Spain, United States, Mexico | Debt Financing, Venture - Series Unknown, Seed | Software, Health Care, Artificial Intelligence | $110k–$7.6M |
|
Ysios Capital
VC Fund
|
10 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Capital Cell
VC Fund
|
10 | Spain, France, United States | Equity Crowdfunding, Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $138k–$3.9M |
|
Alta Life Sciences
VC Fund
|
10 | Spain, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Therapeutics | $3M–$87M |
|
Bullnet Capital
VC Fund
|
9 | Spain, United States, Mexico | Seed, Series A | Software, Manufacturing, Information Technology | $567k–$11M |
|
SOSV
VC Fund
|
9 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
EISMEA
VC Fund
|
9 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Biotechnology, Software | $53k–$2.6M |
|
BStartup - Banc Sabadell
VC Fund
|
8 | Spain, Mexico, United States | Seed, Venture - Series Unknown, Pre-Seed | Software, Artificial Intelligence, Information Technology | $110k–$5.6M |
|
CDTI
VC Fund
|
7 | Spain, United States, Mexico | Venture - Series Unknown, Seed | Software, Information Technology, Health Care | $314k–$5.4M |
|
CRB Inverbío
VC Fund
|
7 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
Xesgalicia
VC Fund
|
7 | Spain, Portugal | Seed, Venture - Series Unknown, Pre-Seed | Software, Biotechnology, B2B | $289k–$5.9M |
|
Nara Capital
VC Fund
|
7 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
Moira Capital Partners
VC Fund
|
7 | Spain | Venture - Series Unknown, Private Equity, Series A | Biotechnology, Apps, Water Purification | $5.5M–$19M |
|
WA4STEAM
VC Fund
|
6 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Artificial Intelligence | $392k–$11M |
|
SOSV HAX
VC Fund
|
6 | United States, Canada, China | Seed, Convertible Note, Pre-Seed | Robotics, Software, Manufacturing | $25k–$4.5M |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
6 | Spain, Ecuador | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $213k–$16M |
|
AdBio partners
VC Fund
|
6 | France, Spain, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Grow Venture Partners
VC Fund
|
6 | Spain, Sweden | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Software | $106k–$9.5M |
|
Healthequity
VC Fund
|
5 | Spain, Switzerland | Series A, Series B, Venture - Series Unknown | Health Care, Biotechnology, Medical | $800k–$22M |
|
European Investment Bank
VC Fund
|
5 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Energy, Biotechnology, Health Care | $8.7M–$587M |
|
Angels Capital
VC Fund
|
5 | Spain, United States, Kenya | Seed, Angel, Pre-Seed | Software, Health Care, E-Commerce | $108k–$2.5M |
|
Seed Capital Bizkaia
VC Fund
|
5 | Spain, Mexico, Belgium | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Manufacturing | $119k–$18M |
|
Amadeus Capital Partners
VC Fund
|
5 | United Kingdom, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $800k–$60M |
|
Union Square Ventures
VC Fund
|
5 | United States, United Kingdom, Germany | Series A, Series B, Seed | Software, Artificial Intelligence, Financial Services | $1.7M–$50M |
|
ICF - Institut Català de Finances
VC Fund
|
4 | Spain, Germany, United Kingdom | Debt Financing, Seed, Series C | Medical, Health Care, Biotechnology | $1.7M–$12M |
|
Clave Mayor
VC Fund
|
4 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $258k–$8.9M |
|
Columbus Venture Partners
VC Fund
|
4 | Spain, United States, United Kingdom | Venture - Series Unknown, Series B, Seed | Biotechnology, Health Care, Medical | $1.7M–$87M |
|
Avançsa
VC Fund
|
4 | Spain | Debt Financing, Venture - Series Unknown, Seed | Software, Manufacturing, Medical Device | $541k–$8.4M |
|
Archipelago Next
VC Fund
|
4 | Spain, United States | Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $296k–$3M |
|
Startupxplore
VC Fund
|
3 | Spain | Pre-Seed, Seed, Convertible Note | Artificial Intelligence, Software, Health Care | $95k–$932k |
|
APEX Ventures
VC Fund
|
3 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$28M |
|
Kereon Partners
VC Fund
|
3 | Spain | Venture - Series Unknown, Seed | Life Science, Biotechnology, Education | $561k–$2.6M |
|
Blue Horizon Corporation
VC Fund
|
3 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $450k–$40M |
|
Namarel Ventures
VC Fund
|
3 | Spain, Italy, Israel | Seed, Series A, Grant | Health Care, Health Diagnostics, Artificial Intelligence | $1.1M–$4.2M |
|
AENU
VC Fund
|
3 | Germany, United States, United Kingdom | Seed, Series A, Series B | Software, Renewable Energy, CleanTech | $2.4M–$87M |
|
EMESA Corporación Empresarial
VC Fund
|
3 | Spain | Seed, Series A | Health Care, Biotechnology, Digital Media | $948k–$3.3M |
|
Pirate Impact
VC Fund
|
3 | Germany, Denmark, Spain | Seed, Series C | EdTech, Software, E-Learning | $3.8M–$106M |
|
Yes VC
VC Fund
|
3 | United States, United Kingdom, India | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $1.5M–$40M |
|
Cofides
VC Fund
|
3 | Spain, Ecuador, Uruguay | Debt Financing, Private Equity, Venture - Series Unknown | Manufacturing, Health Care, Construction | $220k–$692M |
|
Faber
VC Fund
|
3 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $29k–$25M |
| Access all 517 investors in Spain Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Debt Financing
- Geography: Spain, United States, France
Investor stats
- Total investments: 291
- Round size: Seed $400k–$4.7M; Debt Financing $1.2M–$6.5M; Venture - Series Unknown $594k–$5.7M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $63M in 2024
Portfolio highlights
- Mirai RiskTech — AI-driven balance sheet management for banks: ALM and liquidity, FTP, and regulatory reporting on one data model.
- Blinker — Blinker specializes in the wholesale of hardware.
- Fastbase Solutions — Fastbase is to be the platform in cancer diagnostics, bringing precision to cancer patient treatment. This will enable solution of the current problems, which lie in precisely targeting therapies to disease drivers. Fastbase provides a fast and efficient platform technology to measure drug target function. The benefits of precision medicine thatcan be provided by Fastbase would be to deliver treatment to patients selected to respond to therapy, stop the treatment of patients who will not respond, improve patient outcomes and quality of life and also reduce drug costs. Fastbase will be a major player for collaborative opportunities with European Health system.
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national and international levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 225
- Round size: Seed $619k–$5.8M; Grant $167k–$15M; Venture - Series Unknown $846k–$26M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- EpiDisease — EpiDisease provides biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs. The company was founded in 2014 and based in Paterna, Comunidad Valenciana, Spain.
- Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
- Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 35
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M; Venture - Series Unknown $3.3M–$8.9M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of Grupo Corporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 95
- Round size: Seed $110k–$1.2M; Debt Financing $37k–$955k; Venture - Series Unknown $109k–$3.5M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- HOMVERS — Homvers designs and manufactures automated smart furniture systems that physically move to optimize living space in small apartments. Their motorized products, such as beds and desks, retract into walls or ceilings to allow rooms to serve multiple functional purposes throughout the day.
- Barga Group — Grupo Barga is a family owned company specializing in manufacture of internal components for offshore and onshore wind turbine towers.
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa investing in software and deeptech companies across Europe with focus on Spain and Portugal in AI, Cybersecurity, Data, Software Infrastructure and Deeptech
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 180
- Round size: Seed $303k–$3.8M; Series A $1.9M–$21M; Venture - Series Unknown $570k–$6.6M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $140M in 2026
Portfolio highlights
- 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
- Artiso — ARTISO AI provides an AI SaaS platform for fashion brands, suppliers, and creative teams. The platform supports concept development, moodboards, design development, placement prints, all-over prints, tech packs, and campaign content. It connects design, production, and marketing activities within one workflow. The service is intended for fashion professionals managing product development and campaign preparation.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 58
- Round size: Seed $462k–$4.8M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Remolon — Remolon's mission is to reduce food losses and waste while also building a better food system for all.
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
- Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Debt Financing, Seed, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 240
- Round size: Seed $79k–$1.6M; Pre-Seed $188k–$1.2M; Debt Financing $73k–$526k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Pekata — Pekata offers technological solution that allows employee to customize hamper based on personal tastes, dietary restrictions.
- DARWIN Biomed — Biomedical Engineering
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information and communications technologies (ICT) platforms. It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Life Science
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Spain, Italy
Investor stats
- Total investments: 71
- Round size: Seed $158k–$1.6M; Pre-Seed $132k–$514k; Venture - Series Unknown $889k–$16M
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $39M in 2016
Portfolio highlights
- Safeloc Systems — Safeloc Systems is a developer of a real-time location system solution (RTLS) to provide ultra-wideband (UWB) technology services.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio companies Our portfolio Our team Responsible venture capital Aware of the importance of taking responsibility for its potential social and environmental impacts,
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 41
- Round size: Seed $1.3M–$17M; Series A $7M–$57M; Series B $18M–$135M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- ALLOX — ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery. The company combines high-throughput genetics, experimental biology, computational biology, and machine learning to identify functional regions in proteins, including allosteric sites that regulate protein activity. Its proprietary platform uses systematic mutagenesis to measure how thousands of genetic mutations affect protein function, structure, and interactions. These experimental datasets provide the foundation for computational models that predict potential therapeutic targets and guide the design of small-molecule drugs. ALLOX focuses on discovering druggable sites in proteins that have historically been difficult to target, including protein-protein interactions and transcription factors. Its initial research programs focus on oncology, with potential applications across other disease areas. The company also develops its own drug discovery pipeline and collaborates with pharmaceutical and biotechnology partners on research programs. ALLOX originated as a spin-off from the Centre for Genomic Regulation and applies its platform to the discovery of new therapeutic approaches for diseases with limited treatment options.
- Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector in order to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed, Grant
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 61
- Round size: Seed $266k–$10M; Grant $260k–$1.2M; Venture - Series Unknown $330k–$16M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- ALLOX — ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery. The company combines high-throughput genetics, experimental biology, computational biology, and machine learning to identify functional regions in proteins, including allosteric sites that regulate protein activity. Its proprietary platform uses systematic mutagenesis to measure how thousands of genetic mutations affect protein function, structure, and interactions. These experimental datasets provide the foundation for computational models that predict potential therapeutic targets and guide the design of small-molecule drugs. ALLOX focuses on discovering druggable sites in proteins that have historically been difficult to target, including protein-protein interactions and transcription factors. Its initial research programs focus on oncology, with potential applications across other disease areas. The company also develops its own drug discovery pipeline and collaborates with pharmaceutical and biotechnology partners on research programs. ALLOX originated as a spin-off from the Centre for Genomic Regulation and applies its platform to the discovery of new therapeutic approaches for diseases with limited treatment options.
- Bomaq — bomaq manufactures and distributes rough-terrain and four-wheel-drive forklift trucks for material-handling applications. Its product range includes Multi Purpose models with lifting capacities from 3 to 10 tons, as well as customized machines adapted with different cabins, masts, hydraulic configurations, and other options. The equipment is used in sectors such as construction, agriculture, mining, recycling, military operations, timber, and public works. Bomaq also provides after-sales documentation, spare parts, maintenance information, technical support, dealer training, and online training. The company is developing an electric rough-terrain forklift with four-wheel drive and a 2.5-ton lifting capacity.
- Optare Solutions — System Integrator working for Telecom companies worldwide since 2002
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing the private financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Debt Financing, Venture - Series Unknown, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 117
- Round size: Seed $1.2M–$7.6M; Debt Financing $110k–$1.7M; Venture - Series Unknown $560k–$6M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — raised $44M in 2024
Portfolio highlights
- Kintai — Kintai's a lending platform aiming to help small and medium companies with their funding needs. Based on a merchant cash advance model, companies can return their loans on a daily basis with low frictionless amounts.
- Covides — Covides is a prominent Spanish wine cooperative that integrates grape production, vinification, and international commercial distribution for local winegrowers.
- Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 86
- Round size: Series A $3.8M–$65M; Series B $17M–$135M; Series C $29M–$83M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $246M in 2020
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Venture - Series Unknown
- Geography: Spain, France, United States
Investor stats
- Total investments: 53
- Round size: Seed $392k–$1.9M; Equity Crowdfunding $138k–$1.5M; Venture - Series Unknown $617k–$3.9M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- AbTx — Antibody for Therapy
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$34M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 68
- Round size: Seed $1M–$3.2M; Series A $567k–$11M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $87M in 2023
Portfolio highlights
- FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — Optical tweezers and microscopy systems for Cell Mechanics, Molecular Biophysics, Phase Separation and Soft Matter Physics applications
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
European Innovation Council and SMEs Executive Agency (EISMEA)
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3596
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
BStartup is Banco Sabadell’s specialized service in innovative, technological, and digital companies. Regardless of their stage of development—from those just starting out to the largest or most established ones.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 93
- Round size: Seed $110k–$2M; Pre-Seed $110k–$900k; Venture - Series Unknown $121k–$5.6M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Kompanion — Kompanion operates a specialized back-office platform that unifies accounting, payroll, and tax operations in real time for startups, ecommerce entities, and digital agencies. The company combines its proprietary technology with an expert advisory team to manage administrative compliance, financial tracking, and labor documentation. Its value proposition centers on eliminating manual data entry and traditional corporate advisory delays by providing automated onboarding and rapid digital communication.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 38
- Round size: Seed $314k–$2.8M; Venture - Series Unknown $600k–$5.4M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- Oncovision — Oncovision (GEM Imaging S.A.) is a Spanish technologic start-up company created in 2003 with the initiative of the Corpuscular Physics Institute (CSIC) and the University of Valencia.They work in Molecular Vision applied to Health Sciences focusing in: cancer diagnosis and treatment, and advanced research in neurology, oncology, and cardiology.They are a company focused on Molecular Vision, which creates, develops and markets new medical technologies, global innovations with relevant clinical and economic advantages, often representing a breakthrough in current standards of diagnosis and treatment.ONCOVISION´s original, fresh technology, strong intellectual property, top-level clinical evidence, leading global reference centers, and pioneering protocols, is supported by its dynamic cross-functional team. ONCOVISION is opening unprecedented options in the treatment of cancer and serious cardiac and neurological diseases.Their team and the company’s technologies have been recognized by Spanish and European prestigious institutions. In 2007, the company was selected as one of the “20 Best Technologic Companies in Spain” and won the “National Medical Physics 2007 Congress Award” In 2008, it was one of the “20 Best Health Technology Companies in Europe” by the prestigious European Technology Tour, as well as finalist in the “National 25th Aniversary Enisa Award” Prof. Jose María Benlloch, active member of the company, won in 2008, the well-known “Jaime I” award. Scientists, technicians, and technologists of ONCOVISION have dozens of publications and presentations at scientific and medical conferences worldwide.Their shareholding, based in Valencia, was strengthened in August 2006 by the Spanish venture capital firm Bullnet, unifying its proven track in technological and management capabilities with companies in Spain and Portugal. The company is managed by a multi-task professional team with international experience.With proven clinical and scientific results, differentiated technology with enormous potential for future technological and financial capacity, intellectual property and developing lines, ONCOVISION is today ahead in the Spanish and European Health Industry.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 16
- Round size: Seed $3.9M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $82M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, B2B
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 34
- Round size: Seed $289k–$5.9M; Pre-Seed $464k–$2.5M; Venture - Series Unknown $904k–$5.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Moira Capital Partners is private equity firm
Show more...Investment focus
- Industry: Biotechnology, Apps, Water Purification
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: Spain
Investor stats
- Total investments: 18
- Round size: Series A $11M–$19M; Private Equity $7.9M–$19M; Venture - Series Unknown $5.5M–$15M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- NeuronUP — NeuronUP is a platform that provides professionals the ability to access real, when and where they want their exercise routines and their patients time manager and interact directly with their team of professionals in a specialized environment. All this generates a continuous updating of information and content platform, arising from theinter-professional dialogue.
- Xcalibur — Your Strategic Ally in Sustainable Energy Transition. Airborne Survey Solutions for Comprehensive Resource Mapping
- Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.
WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 23
- Round size: Seed $392k–$4.2M; Pre-Seed $671k–$1.2M; Venture - Series Unknown $6.1M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Hair Up Laser — Making alopecia a problem of the past.
- Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.
- Onalabs Inno-hub — Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower thepatients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.
HAX is a program for Hard Tech startups taking their first steps towards commercialization. We provide hands-on support and investment as part of SOSV, a $1B AUM multi-stage venture firm.
Show more...Investment focus
- Industry: Robotics, Software, Manufacturing
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, Canada, China
Investor stats
- Total investments: 699
- Round size: Seed $38k–$4.5M; Pre-Seed $25k–$2M; Convertible Note $100k–$3.8M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- 5QXT — 5QXT is a mining technology company that provides the design, development, and implementation of metal extraction processes.
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Cortysis — Cortysis develops brain stimulation device for rapid spatial and temporal modulation of cortical networks
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Ecuador
Investor stats
- Total investments: 23
- Round size: Seed $213k–$2.3M; Venture - Series Unknown $2.7M–$16M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Orbik Cybersecurity — Orbik Cybersecurity provides testing and compliance services for industrial equipment and embedded electronics.
- Inmedical Therapeutics — Innovative medical devices designed to meet real clinical needs, combining science, know-how and therapeutic research.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain, Sweden
Investor stats
- Total investments: 28
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $11M in 2024
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
- Flavii Therapeutics — Flavii Therapeutics is a biotechnology company that develops epigenetic therapies for central nervous system disorders with high unmet medical need. Flavii’s lead program, FLVA-27, is a first-in-class small-molecule inhibitor of G9a, a key epigenetic regulator of brain function. FLVA-27 demonstrates exceptional brain penetration, favorable PK/PD properties, and a robust safety profile.
Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has a team of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 10
- Round size: Series A $4.4M–$22M; Series B $4.8M–$16M; Venture - Series Unknown $800k–$14M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- SANIFIT — CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.
European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.
Show more...Investment focus
- Industry: Energy, Biotechnology, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 608
- Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$110M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, Kenya
Investor stats
- Total investments: 142
- Round size: Seed $276k–$2.5M; Angel $108k–$1.5M; Pre-Seed $323k–$994k
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- niubiq — niubiq provides artificial intelligence software for sales and marketing teams. Its platform analyzes calls, meetings, videoconferences, and other commercial information to identify customer needs, objections, purchasing patterns, and reasons for won or lost opportunities. The system structures this information into quantitative and qualitative signals, supports CRM updates, and helps teams prioritize actions. niubiq ventas focuses on commercial conversation analysis and sales intelligence. niubiq marketing uses market and sales information to support research, campaigns, messaging, and content development. The platform is intended for B2B organizations whose sales processes depend on customer conversations.
- ruit — Ruit is a multichannel listing and inventory platform built for second-hand businesses. Professional resellers, vintage shops and small warehouses sell the same stock across several marketplaces at once, and they lose most of their time to the same three chores: retyping every listing on every platform, keeping stock in sync so nothing sells twice, and answering buyers scattered across half a dozen inboxes. Ruit removes all three. You upload your catalog once. From a single product sheet, Ruit publishes to Wallapop, Vinted, eBay, Shopify, WooCommerce, PrestaShop and TodoColeccion, adapting titles, categories and attributes to what each marketplace expects. Publishing can be done in bulk or scheduled, so a whole batch of items goes live at the hour your buyers are actually browsing. Once an item is live, Ruit keeps it that way. Stock syncs in real time across every connected channel, so a sale on Vinted removes the item from eBay before a second buyer can reach it. Listings are renewed automatically to stay near the top of marketplace search results, and items can be withdrawn and republished on a schedule without any manual work. Every message and offer from Wallapop, Vinted and eBay arrives in one unified inbox, so a seller answers buyers from a single screen instead of juggling three apps and a browser full of tabs. Ruit also handles the parts of resale that usually happen in a spreadsheet. AI-assisted photo editing cleans up product images. Analytics show what sells, where and at what margin. A built-in price comparator and full price history let sellers research what similar items actually sold for before deciding what to charge, and instant alerts flag opportunities as they appear. Transaction history keeps sales from every channel in one ledger. Ruit works on the web, as a Chrome extension, and as native apps for iOS and Android. It is available in eight languages: Spanish, English, French, Italian, Portuguese, German, Polish and Dutch.
- FitnessKPI — FitnessKPI is a software company that offers business analytics services for sports and fitness centers.
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain, Mexico, Belgium
Investor stats
- Total investments: 37
- Round size: Seed $119k–$2.8M; Series A $2.8M–$13M; Venture - Series Unknown $521k–$18M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- NNEAT — NNEAT's CTEM platform maps full attack surface with live threat intelligence. Fix exposures with agentic action. For mid-market companies & MSSPs.
- Walter Pack — Walter Pack is a manufacturer and seller of parts for the automotive industry.
- Sherpa.ai — Secure AI. Private Data. Sovereign Intelligence. Sherpa.ai platform enables secure distributed AI deployments across enterprises, governments, and regulat
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 283
- Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$60M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $85M in 2023
Portfolio highlights
- iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
- Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Union Square Ventures is a venture capital firm based in New York City.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 555
- Round size: Seed $1.7M–$12M; Series A $3.3M–$24M; Series B $6M–$50M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2026
Portfolio highlights
- Portola — Portola develops the Tolan app, an AI companion that features animated alien personalities for conversational support. The platform matches users with a personalized virtual friend through a personality interview, then evolves that relationship via memory and daily reflection, helping users feel more grounded amid modern pressures. Tolan engages invoice-based chat and can analyze images, enabling natural, context-aware interactions.
- MACHENTA — Machenta develops artificial intelligence and robotics software focused on instant learning for robots. The company builds systems that enable robotic platforms to learn manipulation and control tasks rapidly, reducing the need for extensive manual programming or long training cycles. Its software is used to help automated machines adapt to diverse environments and handle complex physical interaction workflows. Machenta operates in robotics and AI software as well as broader information technology services and experimental research on natural sciences and engineering. Its work targets organizations that deploy or develop robotic systems and require advanced learning capabilities integrated into their hardware and infrastructure.
- Mana Battery — sodium battery electrolyte platform and high-energy cell designs
ICF - Institut Català de Finances provides financial services.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Debt Financing, Seed, Series C
- Geography: Spain, Germany, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $2.4M–$10M; Debt Financing $1.7M–$12M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- ALLOX — ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery. The company combines high-throughput genetics, experimental biology, computational biology, and machine learning to identify functional regions in proteins, including allosteric sites that regulate protein activity. Its proprietary platform uses systematic mutagenesis to measure how thousands of genetic mutations affect protein function, structure, and interactions. These experimental datasets provide the foundation for computational models that predict potential therapeutic targets and guide the design of small-molecule drugs. ALLOX focuses on discovering druggable sites in proteins that have historically been difficult to target, including protein-protein interactions and transcription factors. Its initial research programs focus on oncology, with potential applications across other disease areas. The company also develops its own drug discovery pipeline and collaborates with pharmaceutical and biotechnology partners on research programs. ALLOX originated as a spin-off from the Centre for Genomic Regulation and applies its platform to the discovery of new therapeutic approaches for diseases with limited treatment options.
- Grup Pons — Grup Pons is an agricultural food company that produces estate-grown extra virgin olive oils under the Pons and Janiroc lines. The company manages a vertically integrated model that covers olive cultivation, milling, bottling, and global distribution. Grup Pons also operates Clos Pons, a winery that produces wines, cavas and vermouths that reflect its Mediterranean grape varieties and viticulture. Alongside oils and wines, the portfolio includes bittersweet wine vinegars, sherry vinegars, balsamic-style vinegars, saffron and pantry items. The business serves both professional kitchens and retail consumers, offering single-estate monovarietal oils, organic ranges and curated gift selections. Grup Pons sells its products through international distributors and its own online channels.
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $258k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Series B, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $1.7M–$20M; Series B $28M–$87M; Venture - Series Unknown $16M–$80M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely actively investing — fund raised in 2026
Portfolio highlights
- Sermes — Leaders in offering research services. Clinical operations, pharmacovigilance, legal representation, regulatory advice, data management and outsourced staff.
- Visium — We help companies unlock transformative and sustainable impact through artificial intelligence; delivering enterprise AI strategy, platforms & MLOps that scale securely and drive measurable ROI.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Private equity arm of Generalitat de Catalunya .
Show more...Investment focus
- Industry: Software, Manufacturing, Medical Device
- Stage:Debt Financing, Venture - Series Unknown, Seed
- Geography: Spain
Investor stats
- Total investments: 21
- Round size: Debt Financing $541k–$2.4M; Venture - Series Unknown $2.1M–$8.4M
- Lead/follow: 71% lead, 29% follow
Portfolio highlights
- Floox — Floox llega para diseñar, desarrollar y fabricar puntos de carga rápida en corriente continua para vehículos eléctricos. Somos un equipo de más 120 personas trabajando para revolucionar la movilidad eléctrica y así crear un mundo más efectivo, fácil y sostenible.
- INGALSA — INGALSA specializing in hot-dip galvanizing of steel parts and fasteners.
- NEOS Surgery — NEOS Surgery engages in the research, design, development, and commercialization of medical devices in the field of neuro, spine and other surgical fields.
Archipelago Next support and promote the entrepreneurial ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, United States
Investor stats
- Total investments: 45
- Round size: Seed $296k–$3M; Venture - Series Unknown $626k–$2.4M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Aloja — Aloja is an autonomous AI-driven dynamic pricing platform built specifically for tours, activities, and attractions.
- Modelia — Turn flat-lay photos into realistic on-model shots in minutes with Modelia's AI fashion model generator. No photoshoot or studio needed. Start your free trial.
- Secrets Vault — Secrets Vault has developed and patented innovative cryptography that allows users to rely on ordinary images to access systems and securely protect or share digital data. These images remain unchanged and can be stored or shared anywhere—even publicly—without revealing their purpose.Organizations of all kinds can enable secure authentication,account recovery, or multi-factor authentication in a simple and convenient way, while meeting the most demanding regulations. They can also protect their most sensitive information with full privacy, without the burden of managing passwords. No software or hardware is required on the user’s side. It works directly from any browser or device, and can be deployed in the cloud or on-premise.Secrets Vault is led by seasoned cybersecurity and cryptography entrepreneurs—ex-Scytl, ex-Blueliv—with over 50 patents and 30 scientific papers behind them. The first product leveraging our SDK is an innovative solution designed to safeguard information (the "secret") in a highly secure and user-friendly way by using images that can be openly displayed and shared. Our patented cryptographic protocol can solve numerous challenges in data storage, cybersecurity, and blockchain.Our team comprises seasoned experts with a proven track record of deploying innovative solutions across various sectors. By utilizing advanced cryptography, we have addressed complex challenges in iGaming, Internet Voting, electronic ID, Fintech, and cybersecurity.
Startupxplore is a premium startup investment platform that allows unexperienced and time-savvy investors to diversify their portfolio by co-investing with a group of top-level investors with a proven track record on startup investment.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: Spain
Investor stats
- Total investments: 29
- Round size: Seed $328k–$932k; Pre-Seed $95k–$612k
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Heuristik — Heuristik is a software solution that helps healthcare entities identify and manage patients by combining fingerprint recognition and artificial intelligence. They help with process planning and the administrative management of patients through the use of statistical analysis and proprietary management algorithms.
- Biel Glasses — Biel Glasses is a company from Barcelona developing smart glasses to improve the quality of life of people with low vision.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 62
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $5.7M–$28M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 470+ centers worldwide.
- iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
- Jago Coffee — Jago Coffee serves freshly brewed coffee beverages wherever you are through a fleet of fully electric mobile cafes.
> smart projects
Show more...Investment focus
- Industry: Life Science, Biotechnology, Education
- Stage:Venture - Series Unknown, Seed
- Geography: Spain
Investor stats
- Total investments: 12
- Round size: Seed $1.4M–$1.6M; Venture - Series Unknown $561k–$2.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Lanteko — Lanteko is a company that develops and applies the concepts of the circular economy to the automotive sector. In its first industrial plant it deals with the optimization of processes of the vehicles out of use getting to maximize the recovery, recycling and reuse of components and materials, as well as being pioneers in the remanufacturing of someof them.
- Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
- Transplant Biomedicals — DropCatch.com helps you secure expiring domain names.
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Seed $2M–$10M; Pre-Seed $450k–$6.3M; Series A $2M–$40M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $222M in 2021
Portfolio highlights
- WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
- EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
- foodforecast — AI supported solution to reduce food waste.
Namarel Ventures is an early-stage investment firm that focuses on innovative, data-driven healthcare companies.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Artificial Intelligence
- Stage:Seed, Series A, Grant
- Geography: Spain, Italy, Israel
Investor stats
- Total investments: 8
- Round size: Seed $1.1M–$4.2M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- TeiaCare — TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes.Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families.TeiaCare, based inMilan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
- Magentiq Eye Ltd — AI assisted colonoscopy by MAGENTIQ EYE set a new standard of , recognized by the gastroenterology community for its superior performance.
- Health Lean Analytics — Health Lean Analytics is a Barcelona‑based health‑tech startup that builds hospital‑operations and operating‑room analytics software, using data automation, IoT, and AI to streamline surgical workflows and improve hospital efficiency. Health Lean Analytics is a B2B hospital‑operations platform that focuses on the surgical suite and perioperativeenvironment. It automates data capture from hospital workflows so staff do not have to manually enter information, reducing errors and administrative burden.
AENU is an evergreen impact fund that focuses on stage-agnostic long-term investments in climate-tech and social impact companies.
Show more...Investment focus
- Industry: Software, Renewable Energy, CleanTech
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 67
- Round size: Seed $2.4M–$12M; Series A $8.8M–$53M; Series B $12M–$87M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $188M in 2024
Portfolio highlights
- EPYR — Turning renewable power into high-temperature heat with thermal energy storage
- GALVANY — GALVANY is a climate-tech company focused on end-to-end heat pump and energy-management solutions for homes and buildings.
- Metris Energy — The AI-native operating system for renewable energy.
EMESA Corporación Empresarial
Show more...Investment focus
- Industry: Health Care, Biotechnology, Digital Media
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Seed $948k–$3.3M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Devicare — Devicare is a specialty biotech company dedicated to developing groundbreaking medical treatments in Urology by combining innovative therapies with digital technologies.Devicare is dedicated to improving and easing the lives of patients who suffer from urological diseases and disorders. Devicare's vision is to be a ground-breaking leader inurology with innovative medical treatments, patent protected, clinically-proven and patient-centric.
Pirate Impact is a Family office with focus on stage-agnostic direct investments in climate-tech & social impact companies in the EU & US.
Show more...Investment focus
- Industry: EdTech, Software, E-Learning
- Stage:Seed, Series C
- Geography: Germany, Denmark, Spain
Investor stats
- Total investments: 10
- Round size: Seed $3.8M–$13M; Series C $47M–$106M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- zolar — With the zolar online configurator, homeowners can customise the components of their PV system to suit their individual requirements and receive personal assistance from one of our solar energy experts at the same time. zolar’s extensive network of local partner companies takes care of the installation on site. The Berlin-based start-up employsaround 200 employees across Germany and pursues the vision of installing a PV system on every roof in the world in order to make private households more independent from the mains grid. The dovetailing of energy generation, electricity storage and mobility allows customers to design electrified and smart households. As a next green energy company, zolar enables its customers to become energy providers for their own four walls, neutralise their carbon footprint and, in turn, make an effective contribution to climate protection.
- Labster — Labster empowers educators to reimagine their science courses with immersive online simulations. Request a demo to discover how Labster engages students, trains lab skills, and accelerates learning.
- Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Yes VC invests in category-defining companies at the Pre-Seed and Seed stages. Contact us at partners@yes.vc, we would love to hear from you!
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 86
- Round size: Seed $1.5M–$15M; Pre-Seed $1.5M–$2M; Series A $7M–$40M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Para — Para is the essential money-making platform for all app drivers. Built by drivers for drivers, Para provides more control, money, and opportunities, and puts your best interests at heart.
- Sukha — An all-in-one focus app and distraction blocker for Mac, Windows and Chromebook: AI tasks, binaural music, website and phone blocking, Pomodoro timers.
Cofides provides cost-effective, medium and long-term financial support for viable private investment projects.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Construction
- Stage:Debt Financing, Private Equity, Venture - Series Unknown
- Geography: Spain, Ecuador, Uruguay
Investor stats
- Total investments: 51
- Round size: Debt Financing $220k–$24M; Private Equity $6.1M–$105M; Venture - Series Unknown $23M–$692M
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- BMAT — BMAT is a world leader in music usage monitoring currently working with 30% of all world Copyright Collecting Societies. Started as University spin-off 12 years ago in Barcelona by Scientists, Technologist and IT experts with more than 250+ Research publications, patents and books, BMAT has its own technologies developed throughout the last 17years.BMAT monitors uninterruptedly more than 5,500 sources of music including radios, TVs, streams and venues around the world and compares against 50M unique songs to serve their clients from all around the world - from the Philippines to Chile. Today their monitoring platform delivers 26 million identifications monthly and overviews 1 trillion digital transactions yearly.
- WindWaves — WindWaves manufactures fixed and floating structures for offshore wind farms and steel foundations for marine energy projects. The company also undertakes naval construction, including steel vessels and aluminum ferries, serving both civil and military programs. WindWaves provides engineering, logistics, quality control, and project managementservices across offshore and shipbuilding activities. Its teams specialize in large steel and aluminum fabrication, block prefabrication, and on-site assembly for complex marine structures. WindWaves supports serial production of offshore wind platforms and jackets, working with a developed supply chain for major energy clients and shipyards.
- Hydnum Steel — Explore Hydnum Steel's vision for a greener future. Learn about our innovative steel solutions that prioritize sustainability and technology.
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 97
- Round size: Seed $549k–$5.2M; Pre-Seed $29k–$3M; Series A $2.5M–$25M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
- InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
Biotech Investor funding in Spain at a glance
Stats across 803 deals from 517 investors.
Access all 517 investors in Spain Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 517 investors investing in Spain Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!